Plasma cystatin C was also indicated to modulate the clinical expression of cognitive decline; a significant anticipation of the conversion to dementia was observed in MCI subjects, when the detected plasma cystatin C levels were below 1,067 ng/ml (Ghidoni et al., 2010). The gene discussed is CST3; the disease is dementia.